Precision Medicine Group

Precision Medicine Group works with pharmaceutical and life-sciences clients across the product development and commercialisation lifecycle. Founded in 2012, the company brings together disciplines including advanced lab sciences, translational informatics, data analytics and insights, regulatory affairs, payer insights and marketing communications, with particular focus on biomarker-driven research and development and manufacturing support.

The group operates through two units. Precision for Medicine provides biomarker-driven research and development services to pharmaceutical and life-sciences clients. Precision AQ provides commercialisation services supporting life science organisations from launch through product maturity.

Headquartered operations span a global footprint, with a team of some 3,500 experts. The company describes itself as an integrated, multi-disciplinary team, combining scientific, informatics, regulatory and commercial expertise around a stated aim of improving the drug development process. Its client base covers pharmaceuticals, biotechnology, drug development and healthcare commercialisation.

Further information is available at https://precisionmedicinegrp.com/.